“I expect the role of LAI Invega Trinza on schizophrenia”
In the market of schizophrenia, whose key of treatment is to prevent recurrence prevention, the domestic approval of ‘Invega Trinza,’ a long-acting injection(hereinafter referring to LAI), has attracted attention.
At the Janssen Korea’s MFDS(Ministry of Food and Drug Safety) Approval Commemorati...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
